Star Imaging SME IPO
ListedBSE SMEOpens 8 August 2025Closes 12 August 2025
Star Imaging & Path Lab Ltd. is a healthcare service provider that offers comprehensive diagnostic imaging services and clinical laboratory tests, including both routine and specialized tests. The company's services…
Star Imaging & Path Lab Ltd. is a healthcare service provider that offers comprehensive diagnostic imaging services and clinical laboratory tests, including both routine and specialized tests. The company's services span across various medical fields such as Radiology (X-ray, CT Scan, Mammography, 4D ultrasound, Bone Mineral Density), Pathology (Haematology, Microbiology, PCR, Histopathology, Immunology & Bio Chemistry), and Cardio-diagnostics. The company operates on a mixed business model, serving B2G (Public-private partnership model), B2C (direct consumers), and B2B (private hospitals) segments. In Fiscal 2024, B2G contributed 58.46% of the revenue, B2C 34.67%, and B2B 6.87%.
Show moreShow less
Key ratios
As per RHP / filingsTimeline
IPO Opens
8 Aug 2025
IPO Closes
12 Aug 2025
Allotment
13 Aug 2025
Listing
18 Aug 2025
IPO Timeline & Listing Details
| Event | Date |
|---|---|
| IPO Open Date | 8 August 2025 |
| IPO Close Date | 12 August 2025 |
| Allotment Date | 13 August 2025 |
| Listing Date | 18 August 2025 |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Individual | 2 | ₹2,84,000 |
SHNI (Min) | 3 | ₹4,26,000 |
SHNI (Max) | 7 | ₹9,94,000 |
BHNIAbove ₹10,00,000 | 8 | ₹11,36,000 |
IPO Objectives
- To Meet Working Capital Requirement.
- Repayment/prepayment of certain borrowings availed of by the Company.
- Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities.
- General corporate purposes.
Strengths
- The company offers a comprehensive range of diagnostic services, including radiology and pathology, positioning it as a one-stop-shop for medical tests with specialized expertise.
- Its diverse business model serves government agencies, businesses, and individuals, with the stable government segment providing a consistent revenue stream.
- The company has shown strong financial growth, with revenue increasing by 5% and profit after tax rising by 28% between FY24 and FY25.
- The money from the IPO will be used for working capital and to buy refurbished medical equipment to enhance its facilities and improve operational efficiency.
- The company ensures accuracy and reliability of results through its proper sample collection and processing procedures.
Weaknesses
- There is a high reliance on the government segment for revenue, which can make the company vulnerable to government budget cuts or payment delays.
- The business requires a lot of working capital, and a significant portion of the IPO funds is needed to meet these ongoing financial needs.
- The company faces intense competition from both national and regional players in the diagnostics market, which can put pressure on its prices.
- With the company's P/E ratio not available, it's difficult for investors to accurately value it and compare it with competitors.
- The company's use of refurbished medical equipment may lead to higher long-term maintenance costs and could limit its technological capabilities in a fast-changing industry.
Financial Performance
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets (₹ Cr.) | 98.16 | 81.64 | 61.23 |
| Revenue (₹ Cr.) | 83.79 | 79.97 | 58.68 |
| PAT (₹ Cr.) | 15.96 | 12.45 | 0.58 |
| Net Worth (₹ Cr.) | 47.15 | 31.35 | 18.93 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0x | 0x | 12.85x |
| NII | 0.13x | 0.39x | 4.38x |
| S-HNI | 0.09x | 0.43x | 2.89x |
| B-HNI | 0.15x | 0.36x | 5.12x |
| RII | 0.05x | 0.41x | 2.3x |
| EMP | 0x | 0.1x | 0.31x |
| Total | 0.05x | 0.28x | 5.66x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 8,71,000 | 1,11,88,000 | 158.87 |
| NII | 6,57,000 | 28,75,000 | 40.83 |
| Small NII | 2,19,000 | 6,33,000 | 8.99 |
| Big NII | 4,38,000 | 22,42,000 | 31.84 |
| RII | 15,28,000 | 35,16,000 | 49.93 |
| EMP | 52,000 | 16,000 | 0.23 |
| Total | 31,08,000 | 1,75,95,000 | 249.85 |
Company Details
- Star Imaging & Path Lab Ltd.
- 4B/4, Tilak Nagar, Near Sant Pura, Tilak Nagar West Delhi, New Delhi-110018
- +91 9990019189
- cs@starimaging.in
- https://www.starimaging.in/
Registrar Details
- Kfin Technologies Limited
- 04067162222, 04079611000
- sipll.ipo@kfintech.com
- https://kosmic.kfintech.com/ipostatus/
Frequently Asked Questions
See live numbers on GMP, Subscription, and Allotment pages.
Star Imaging SME IPO News & Updates
Follow the latest updates for Star Imaging SME IPO, including grey market moves and allotment news.
Star Imaging SME IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Star Imaging SME IPO Details
Issue size, price, financials, and company info
Star Imaging SME IPO GMP
Live grey market premium and listing estimate
Star Imaging SME IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Star Imaging SME IPO Allotment
Allotment date, chances, and check by PAN
Star Imaging SME IPO Review
SWOT, strengths, risks, and IPO review
Star Imaging SME IPO FAQ
Common questions on dates, GMP, and allotment
Star Imaging SME IPO Registrar
Registrar website and how to check allotment
Star Imaging SME IPO Timeline
Open, close, allotment, and listing dates
Star Imaging SME IPO News
Updates, blogs, and latest IPO news
Sources
We match Star Imaging SME IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- Kfin Technologies LimitedOfficial site to check allotment status for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.